CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $10.17B, above the global median of $1.18B
- FinancialsAltman Z-Score 13.29: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.13%Below 5Y avg (0.31%)
Annual Rate
INR 2.40Paid semi-annual
Payout Ratio
9.9%Sustainable
Last Ex-Dividend
May 8, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
973.64BINR10.17B · vs all stocks (USD)
Trailing P/E
88.94xRevenue (TTM)
72.70BINR759.60M · vs all stocks (USD)
Profit Margin
15.04%Beta
0.3570xvs all stocks
52-Week Change
106.37%vs all stocks
Forward Annual Dividend Yield
0.13%vs all stocks
Market Capitalization
973.64BINR10.17B · vs all stocks (USD)
Enterprise Value
998.18BINR10.43B · vs all stocks (USD)
Trailing P/E
88.94xForward P/E
63.77xPEG Ratio
1.56xPrice to Sales (TTM)
13.39xPrice to Book (MRQ)
18.35xEnterprise to Revenue
13.73xEnterprise to EBITDA
48.91xGross Margin
62.69%Profit Margin
15.04%Operating Margin
25.39%Return on Assets (TTM)
8.46%Return on Equity (TTM)
16.36%Revenue (TTM)
72.70BINR759.60M · vs all stocks (USD)
Revenue per Share (TTM)
134.69INRUpdated Aug 21, 2026Quarterly Revenue Growth
29.10%Gross Profit (TTM)
43.21BINR451.55M · vs all stocks (USD)
EBITDA (TTM)
20.50BINR214.19M · vs all stocks (USD)
Net Income (TTM)
10.93BINR114.25M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
125.50%Operating Cash Flow (TTM)
16.23BINR169.64M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
8.89BINR92.87M · vs all stocks (USD)
Forward Annual Dividend Rate
2.40INRUpdated Aug 21, 2026Forward Annual Dividend Yield
0.13%vs all stocks
Trailing Annual Dividend Rate
2.00INRUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.11%vs all stocks
5-Year Average Dividend Yield
0.31%vs all stocks
Payout Ratio
9.89%Minority Interest (Equity)
1.31BINRFY2026 · Mar 31, 2026Revenue
67.21BINRFY2026 · Mar 31, 2026Cost of Goods Sold
27.64BINRFY2026 · Mar 31, 2026Gross Profit
39.58BINRFY2026 · Mar 31, 2026Operating Income
13.06BINR136.50M · vs all stocks (USD)
Pre-tax Income
11.82BINRFY2026 · Mar 31, 2026Income Tax Expense
2.92BINRFY2026 · Mar 31, 2026Net Income
8.90BINRFY2026 · Mar 31, 2026EBIT
13.43BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
18.30BINRFY2026 · Mar 31, 2026Research & Development
276.60MINRFY2026 · Mar 31, 2026Selling, General & Administrative
2.43BINRFY2026 · Mar 31, 2026Other Operating Expenses
10.93BINRFY2026 · Mar 31, 2026Non-operating Interest Income
65.70MINRFY2026 · Mar 31, 2026Non-operating Interest Expense
1.61BINRFY2026 · Mar 31, 2026EPS (Basic)
16.47INRFY2026 · Mar 31, 2026EPS (Diluted)
16.45INRFY2026 · Mar 31, 2026Basic Shares Outstanding
539.74MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
539.74MSharesFY2026 · Mar 31, 2026Minority Interests (P&L)
-13.50MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
11.02BINRFY2026 · Mar 31, 2026Free Cash Flow
387.60MINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
1.13BINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
11.82BINRFY2026 · Mar 31, 2026Stock-based Compensation
109.40MINRFY2026 · Mar 31, 2026Other Non-cash Items
1.58BINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-1.81BINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-681.70MINRFY2026 · Mar 31, 2026Capital Expenditures
-10.63BINRFY2026 · Mar 31, 2026Net Acquisitions
-757.20MINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-11.39BINRFY2026 · Mar 31, 2026Long-term Debt Issuance
2.55BINRFY2026 · Mar 31, 2026Long-term Debt Payments
-5.72BINRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
-2.45BINRFY2026 · Mar 31, 2026Common Dividends Paid
-863.30MINRFY2026 · Mar 31, 2026Other Financing Charges
423.80MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
-5.86BINRFY2026 · Mar 31, 2026Shares Outstanding
540.31MSharesUpdated Aug 21, 2026Float Shares
363.28MSharesUpdated Aug 21, 2026% Held by Insiders
32.03%vs all stocks
% Held by Institutions
32.59%vs all stocks
Total Cash (MRQ)
1.14BINR11.88M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.11INRUpdated Aug 21, 2026Total Debt (MRQ)
25.18BINR263.16M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4637xCurrent Ratio (MRQ)
1.33xBook Value per Share (MRQ)
98.17INRUpdated Aug 21, 2026Total Assets
105.11BINR1.10B · vs all stocks (USD)
Total Current Assets
48.29BINRFY2026 · Mar 31, 2026Total Liabilities
50.80BINRFY2026 · Mar 31, 2026Total Non-current Assets
56.82BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
14.44BINRFY2026 · Mar 31, 2026Total Current Liabilities
36.35BINRFY2026 · Mar 31, 2026Cash
1.13BINRFY2026 · Mar 31, 2026Cash Equivalents
0.00INRFY2026 · Mar 31, 2026Cash & Cash Equivalents
1.13BINRFY2026 · Mar 31, 2026Accounts Receivable
21.55BINRFY2026 · Mar 31, 2026Inventory
23.42BINRFY2026 · Mar 31, 2026Accounts Payable
12.52BINRFY2026 · Mar 31, 2026Short-term Debt
17.96BINRFY2026 · Mar 31, 2026Other Current Liabilities
309.10MINRFY2026 · Mar 31, 2026Long-term Debt
7.23BINRFY2026 · Mar 31, 2026Common Stock (Book)
1.08BINRFY2026 · Mar 31, 2026Retained Earnings
44.29BINRFY2026 · Mar 31, 2026Total Shareholders' Equity
54.31BINR567.52M · vs all stocks (USD)
52-Week Low
823.10INRUpdated Aug 21, 202652-Week High
1.87KINRUpdated Aug 21, 202652-Week Change
106.37%vs all stocks
Beta
0.3570xvs all stocks
50-Day MA
1.62KINRUpdated Aug 21, 2026200-Day MA
1.23KINRUpdated Aug 21, 2026Avg 10-Day Volume
1.40MSharesUpdated Aug 21, 2026Avg 30-Day Volume
1.93MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
20.26INRUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 13.29: safe zoneNotable
Altman Z-Score: 13.29
High earnings qualityNotable
Earnings Quality Score: 0.61
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $10.17B, above the global median of $1.18BNotable
Market cap (USD): 10,173,591,703.319Global Median: 1,179,398,897.704
Revenue is $759.6M, above the global median of $534.05MNotable
Revenue (USD): 759,604,660.863Global Median: 534,052,387.958
Levered free cash flow is $92.87M, above the global median of $19.19MNotable
Levered free cash flow (USD): 92,869,667.1Global Median: 19,189,974.917
Companies that share the same coordination system — how they create, deliver, or capture value.
Abivax SA
Tier 1ProductionApproval-Gated PipelineRule
Apogee Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Dr. Reddy's Laboratories Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Praxis Precision Medicines Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ionis Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Bio-Rad Laboratories Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Insulet Corporation
Tier 1ProductionApproval-Gated PipelineRule
Kymera Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Fosun Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
RemeGen Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Selcuk Ecza Deposu Ticaret ve Sanayi A.S.
1 interpretationReceivables Heavy and Growing